Andrew Collier

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

Medicine, Endocrinology, Nephrology +15

Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland

Stuart J. McGurnaghan, Amanda Weir, Jen Bishop et al. · The Lancet Diabetes & Endocrinology · 2020 · 341 citations · Full text

Public Health, Chronic Disease Prevention, Preventive Medicine +12

One step closer to understanding the role of bacteria in diabetic foot ulcers: characterising the microbiome of ulcers

Karen Smith, Andrew Collier, Lindsay E. O’Donnell et al. · BMC Microbiology · 2016 · 145 citations · Full text

Life Sciences, Microbiology, Bacteriology +16

Free Radical Activity and Hemostatic Factors in NIDDM Patients With and Without Microalbuminuria

Andrew Collier, Ann Rumley, A G Rumley et al. · Diabetes · 1992 · 122 citations

Medicine, Hematology, Internal Medicine +13